Dr Freddie Dudbridge is the Commercial Development and Strategy Manager at Constructive Bio.
Constructive Bio rewrites genomes to build the biomolecules of the future. The company’s unique technology turns living cells into biofactories creating sustainable new materials and therapeutics.
Through access to breakthrough science from Professor Jason Chin at the MRC Laboratory of Molecular Biology, Constructive Bio can rewrite and recode entire genomes and engineer the cell’s translational machinery to incorporate multiple exotic amino acids in a single molecule in a fully programmable way. This breakthrough technology allows Constructive Bio to scalably build large DNA and synthesise new biomolecules incorporating multiple non-canonical amino acids, with novel properties and applications across science and industry.